Agilent Technologies, Inc. $A Shares Bought by Oppenheimer Asset Management Inc.

Oppenheimer Asset Management Inc. lifted its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 75.9% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 96,824 shares of the medical research company’s stock after buying an additional 41,794 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Agilent Technologies were worth $12,861,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. Fiduciary Trust Co raised its stake in Agilent Technologies by 1.6% during the 3rd quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock worth $633,000 after acquiring an additional 77 shares in the last quarter. Sapient Capital LLC lifted its position in Agilent Technologies by 4.2% in the first quarter. Sapient Capital LLC now owns 2,105 shares of the medical research company’s stock valued at $240,000 after acquiring an additional 85 shares during the last quarter. Plan A Wealth LLC boosted its stake in Agilent Technologies by 3.2% in the fourth quarter. Plan A Wealth LLC now owns 2,959 shares of the medical research company’s stock valued at $403,000 after acquiring an additional 92 shares in the last quarter. IHT Wealth Management LLC boosted its stake in Agilent Technologies by 4.9% in the fourth quarter. IHT Wealth Management LLC now owns 2,041 shares of the medical research company’s stock valued at $278,000 after acquiring an additional 96 shares in the last quarter. Finally, KPP Advisory Services LLC grew its holdings in shares of Agilent Technologies by 2.4% during the second quarter. KPP Advisory Services LLC now owns 4,382 shares of the medical research company’s stock worth $582,000 after purchasing an additional 103 shares during the last quarter. Institutional investors and hedge funds own 87.41% of the company’s stock.

Agilent Technologies Trading Down 0.5%

NYSE A opened at $148.55 on Friday. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. The firm has a market cap of $41.96 billion, a PE ratio of 29.83, a P/E/G ratio of 2.64 and a beta of 1.25. Agilent Technologies, Inc. has a one year low of $108.35 and a one year high of $160.27. The firm’s fifty day moving average is $135.38 and its two-hundred day moving average is $125.56.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business had revenue of $1.83 billion during the quarter, compared to analysts’ expectations of $1.80 billion. During the same period in the prior year, the company earned $1.31 earnings per share. The business’s revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Analysts expect that Agilent Technologies, Inc. will post 6.03 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th were paid a dividend of $0.255 per share. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $1.02 annualized dividend and a yield of 0.7%. Agilent Technologies’s dividend payout ratio is currently 20.48%.

Analysts Set New Price Targets

A number of research firms have recently commented on A. Royal Bank Of Canada started coverage on Agilent Technologies in a research report on Wednesday, May 27th. They set an “outperform” rating and a $153.00 target price on the stock. Wall Street Zen raised Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Sunday, August 2nd. HSBC dropped their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research note on Wednesday, June 3rd. Bank of America raised Agilent Technologies from a “neutral” rating to a “buy” rating and cut their price target for the stock from $150.00 to $145.00 in a research report on Thursday, May 28th. Finally, Barclays boosted their price objective on Agilent Technologies from $145.00 to $150.00 and gave the company an “overweight” rating in a research note on Wednesday, June 24th. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Agilent Technologies has an average rating of “Moderate Buy” and a consensus price target of $160.24.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.